Back
Sarepta Therapeutics Stock Predictions
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
Sign up now to get this report and avoid a high-yield dividend trap - Yours FREE.
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
151.67
Seasonality Move:
21.71%
7 Day Trial
ALL ACCESS PASS
$
7
Watch this free video on trading overnight options
Get the free overnight options training here.Sarepta Therapeutics Stock Forecast
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 50% based on the past 27 years of stock performance.
- Sarepta Therapeutics has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Sarepta Therapeutics Stock Undervalued?
The current Sarepta Therapeutics [SRPT] share price is $151.73. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal. - SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 50% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics overpriced?
- Sarepta Therapeutics has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
55.25
Prediction Charts
Market Cap:
14.34B
Price in USD:
151.73
Volume:
641.93K
Beta:
1.06
Technical Analysis
SMA50:
132.55
SMA100:
129.23
SMA200:
116.53
52-Wk Change:
35.61%
Stock Predictions
-
Is Sarepta Therapeutics stock public?
Yes, Sarepta Therapeutics is a publicly traded company. -
What is the Sarepta Therapeutics stock quote today?
The Sarepta Therapeutics stock price is 151.73 USD today. -
How to buy Sarepta Therapeutics stock online?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-14 | 124.09 | 122.84 | 125.89 | 120.34 |
| Jun-17 | 122.53 | 116.83 | 122.55 | 116.50 |
| Jun-18 | 117.01 | 117.52 | 120.29 | 116.77 |
| Jun-20 | 117.53 | 123.56 | 123.73 | 115.74 |
| Jun-21 | 161.97 | 160.77 | 173.25 | 157.25 |
| Jun-24 | 162.25 | 163.74 | 168.31 | 162.00 |
| Jun-25 | 164.52 | 158.06 | 164.52 | 157.38 |
| Jun-26 | 155.75 | 156.91 | 157.84 | 151.26 |
| Jun-27 | 156.72 | 157.96 | 158.74 | 152.74 |
| Jun-28 | 157.96 | 157.74 | 159.77 | 156.00 |
| Jul-1 | 158.00 | 156.75 | 162.95 | 155.18 |
| Jul-2 | 156.46 | 154.20 | 156.70 | 153.65 |
| Jul-3 | 154.00 | 153.11 | 155.95 | 151.25 |
| Jul-5 | 152.57 | 151.73 | 152.58 | 150.98 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.